Lexeo Therapeutics, Inc.

NASDAQ: LXEO
Share price (12/23/24): $6.21
Market cap (12/23/24): $205 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Updated info for already-effective prospectus

Prospectus supplement

Prospectus supplement

Prospectus supplement

Ownership Filter

Townsend Richard Nolan

Townsend Richard Nolan

Cholmondeley Paula H

Eventide Asset Management, LLC

Janus Henderson Group plc

News Filter

Appoints Kyle Rasback as Chief Financial Officer

Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results

Announces Positive Interim Data for LX1001, First-Ever Gene Therapy to Impact the Underlying Genetic Cause of APOE4-Associated Alzheimer’s Disease, at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Investor Presentation

Reports Second Quarter 2024 Financial Results and Operational Highlights

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC